DRUG CONSUMPTION DATABASES INEUROPE

➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạm

Loại tài liệu: WORD

Số trang: 166 Trang

Tài liệu: ✅ ĐÃ ĐƯỢC PHÊ DUYỆT

TẢI VỀ

Nội dung chi tiết: DRUG CONSUMPTION DATABASES INEUROPE

DRUG CONSUMPTION DATABASES INEUROPE

National administrative drug consumption data sourcesProtectHwmaccefnốemotopcal Research Oft Outcomes of Therajeutxs by a Eiropea'1 ConscrtwmDRUG CONS

DRUG CONSUMPTION DATABASES INEUROPE SUMPTION DATABASES INEUROPEMaster documentFirst version August 2011Updated version October 2012WP2 Framework for pharmacoepidemiological studiesWG3 Dr

ug utilization dataNational administrative drug consumption data sourcesPROTECT: Pharmacoepidemiological Research on Outcomes of Therapeutics by aEuro DRUG CONSUMPTION DATABASES INEUROPE

pean ConsortiumThe PROTECT project is receiving funding from the European Community‘s SeventhFramework Programme (FP7/2007-2013) for the Innovative Me

DRUG CONSUMPTION DATABASES INEUROPE

dicines Initiative (IM1)IMI Call topic: Call No.6: Strengthening the Monitoring of Benefit.'Risk (Call Identifier:IMI_Call_2008_l_06). Grant agreement

National administrative drug consumption data sourcesProtectHwmaccefnốemotopcal Research Oft Outcomes of Therajeutxs by a Eiropea'1 ConscrtwmDRUG CONS

DRUG CONSUMPTION DATABASES INEUROPE uggested citation: Ferrer p, Ballarín E. Sabaté M. Rottenkolber M. Hasford J. Tatt I, Schoonen M. Fortuny J. Petri H. Goh KL. Yeboa s. Solari Pand Iba

nez L.. on behalf of the PROTECT project. Drug Consumption Databases in Europe. Barcelona. August 2012. 170pagesNational administrative drug consumpti DRUG CONSUMPTION DATABASES INEUROPE

on data sourcesWP2 Co-leaders: Olaf Klungel (UU) and Robert Reynolds (Pfizer).WG3 Coordinators: Luisa Ibanez (FICF) and Hans Petri (Roche) up to March

DRUG CONSUMPTION DATABASES INEUROPE

2012. Joan Fortuny (Novartis) from April 2012First version authors: Pili Ferrer (FICF), Elena Ballarin (FICF), Monica Sabaté (FICF), Hans Petri (Roch

National administrative drug consumption data sourcesProtectHwmaccefnốemotopcal Research Oft Outcomes of Therajeutxs by a Eiropea'1 ConscrtwmDRUG CONS

DRUG CONSUMPTION DATABASES INEUROPE FICF). Mònica Sabaté (FICF).Joan Fortuny (Norvartis). Iain Tait (Roche). Marieke Schoonen (Amgen). Marietta Rottenkolber (LMU), Joerg Hasford (LMU) an

d Luisa Ibanez (FICF).Reviewers (all versions): Olaf Klungel (UU). Robert Reynolds (Pfizer), Joan-Ramon Laporte (FICF).Conflicts of interest: The rese DRUG CONSUMPTION DATABASES INEUROPE

arch leading to these results was conducted as part of the PROTECT consortium (Pharmacoepidemiological Research on Outcomes of Therapeutics by a Europ

DRUG CONSUMPTION DATABASES INEUROPE

ean ConsorTium), www-imi-protect.eu, which is a private-public partnership coordinated by the European Medicines Agency. The PROTECT project has recei

National administrative drug consumption data sourcesProtectHwmaccefnốemotopcal Research Oft Outcomes of Therajeutxs by a Eiropea'1 ConscrtwmDRUG CONS

DRUG CONSUMPTION DATABASES INEUROPE osed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.The vie

ws expressed are those of the authors only.Authors’ disclosure information: Joan Fortuny. Iain Tatt. Marieke Schoonen. Hans Petri and Robert Reynolds DRUG CONSUMPTION DATABASES INEUROPE

belong to EFPIA (European Federation of Plrarmaceutical Industries and Association) member companies in the IMI JU and costs related to their part in

DRUG CONSUMPTION DATABASES INEUROPE

the research were carried by the respective company as in-kind contribution under the IMI JU scheme.Working Package 2 co-leaders and Working Group 3 p

National administrative drug consumption data sourcesProtectHwmaccefnốemotopcal Research Oft Outcomes of Therajeutxs by a Eiropea'1 ConscrtwmDRUG CONS